WeVote
Log In

Bill

Bill

HB 4756

Relating to certain advertisements for prescription drugs.

89th Legislature (2025) Introduced by Cecil Bell

Texas bill regulating prescription drug advertisements, referred to committee; specific restrictions not yet detailed in public filings.

Referred to Trade, Workforce & Economic Development
#advertising(s2680) #business&commerce--general(i0050) #business&commerce--tradepractices(i0006) #health--general(i0385) #medicine&prescriptiondrugs(s7338)
0
WeVote Research Nonpartisan
Bill Summary · HB 4756

Legislative bill overview

HB 4756 regulates pharmaceutical advertising practices in Texas, though the specific provisions aren't detailed in the available filing information. The bill was introduced by Representative Cecil Bell and referred to the Trade, Workforce & Economic Development Committee. As of April 2025, it remains in early legislative stages.

Why is this important

Prescription drug advertising significantly influences public health decisions and healthcare costs. Regulations in this area affect how pharmaceutical companies communicate with consumers, which can impact medication awareness, patient autonomy, and overall pharmaceutical market competition. Texas legislation on this topic could serve as a model for other states.

Potential points of contention

  • Free speech vs. consumer protection: Balancing First Amendment protections for commercial speech against preventing misleading pharmaceutical claims
  • Enforcement scope: Whether regulations apply equally to direct-to-consumer advertising, social media promotion, and professional marketing channels
  • Economic impact: Industry concerns about compliance costs and competitive disadvantages versus public health advocates' concerns about adequate disclosure requirements

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.